Clinical Trials Logo

Clinical Trial Summary

A double-blind, placebo-controlled, randomized dose ranging study for the use of 3VM1001 Cream, 2g three times daily, 3g three times daily, or 3g four times daily for treatment of chronic pain associated with osteoarthritis of the knee compared to inactive placebo.


Clinical Trial Description

The study is a double-blind, placebo-controlled, dose ranging study for the use of 3VM1001 Cream, 2g three times daily, 3g three times daily, or 3g four times daily for the treatment of chronic pain associated with osteoarthritis of the knee compared to the inactive vehicle as a placebo.

A maximum of 120 subjects will be enrolled. Subjects will self-treat for 7 (+2) days, applied in the morning and at bed time.

The active pharmaceutical ingredient is copper. The proposed doses in the study are less than 2% of the upper limit of the RDA (0.9 mg/day, upper limit 10mg/day).

Rescue medication is acetaminophen, up to ~2g daily (Up to six Tylenol Regular Strength tablets). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03142178
Study type Interventional
Source CDA Research Group, Inc.
Contact
Status Completed
Phase Phase 1/Phase 2
Start date April 30, 2017
Completion date June 1, 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04525950 - Robotized Navigation Compared to Conventional Technique in Total Knee Replacement N/A
Active, not recruiting NCT03312465 - Anatomical Shoulder Domelock System Study
Recruiting NCT03260465 - Clinical Study With the seleXys PC and the RM Pressfit Vitamys Cup N/A
Active, not recruiting NCT02154516 - Pilot Study Evaluating the Safety and Efficacy of a New Hard-on-Hard Total Hip Replacement System N/A
Completed NCT02784626 - Intraoperative Sedatives and Postoperative Pain Phase 4
Completed NCT02967874 - Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment Phase 1/Phase 2
Withdrawn NCT02341079 - Intraoperative Liposomal Bupivacaine Injection in Primary Total Knee Arthroplasty Phase 2/Phase 3
Terminated NCT03245320 - Clinical Evaluation of the TITAN™ Total Shoulder System
Recruiting NCT03958370 - Validation of Consumer Activity Monitors in Postoperative Total Arthroplasty Patients
Recruiting NCT06080412 - Blueprint® Mixed Reality Pilot Study
Active, not recruiting NCT03631030 - Cooled RF Lesion MRI Characteristics N/A
Withdrawn NCT02799654 - Excia T Cementless EBRA Study N/A
Completed NCT00105677 - Understanding the Differences in the Management of Patients With Arthritis of the Knee or Hip N/A
Terminated NCT02435420 - A Retro-prospective Study of Total Hip Arthroplasty With EMPERION Modular Primary Stem in Australian Centres (HISTORIC) N/A
Completed NCT02276833 - Use of Autologous Adipose-Derived Stromal Vascular Fraction to Treat Osteoarthritis of the Knee Phase 1